Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors
NCT04552847
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
85
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
Al18F-NOTA-octreotide
DEVICE:
PET/CT
DEVICE:
PET/MR
Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
[object Object]
[object Object]
[object Object]